Insomnia Pipeline Therapeutics Development Market Report in H1 2017


Posted May 26, 2017 by devpatel

Insomnia Pipeline Market Review, H1 2017 report provides an overview of the Insomnia pipeline landscape. Report @ Goo.gle/Insomnia-Pipeline-Report .

 
The Insomnia Pipeline Market Review, H1 2017 Report provides an overview of the Insomnia (Central Nervous System) pipeline landscape. The Insomnia Pipeline Market Report provides a pipeline guide reviews for reviews key companies involved in Insomnia (Central Nervous System) therapeutics and enlists all their major and minor projects.
Insomnia is a sleep disorder that is characterized by difficulty falling and/or staying asleep. Symptoms include difficulty falling asleep at night, irritability, depression or anxiety, tension headaches and distress in the stomach and intestines. Risk factors include age, mental health disorder, stress and shift working.
Pharmaceutical and Healthcare latest pipeline Report Insomnia - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Insomnia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1010752 – This report is available at up to 25% Discount till June 02nd 2017.
The latest Pharmaceutical and Healthcare disease pipeline guide Insomnia - Pipeline Review, H1 2017, provides an overview of the Insomnia (Central Nervous System) pipeline landscape. The Key Company Profiles are Actelion Ltd, Alexza Pharmaceuticals Inc, Athenex Inc, Eisai Co Ltd, Evotec AG, Grupo Ferrer Internacional SA, Heptares Therapeutics Ltd, Intec Pharma ltd, Intra-Cellular Therapies Inc, Johnson & Johnson, Leading BioSciences Inc, Merck & Co Inc, Neurim Pharmaceuticals Ltd, Novartis AG, Reviva Pharmaceuticals Inc, Shionogi & Co Ltd, Taisho Pharmaceutical Co Ltd, Takeda Pharmaceutical Company Ltd, Yangtze River Pharmaceutical Group.
The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III and Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 10, 4, 9 and 4 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 3 molecules, respectively.
Insomnia (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Inquire more on this Research Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1010752
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Insomnia (Central Nervous System).
The pipeline guide reviews pipeline therapeutics for Insomnia (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Insomnia (Central Nervous System) therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Insomnia (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Insomnia (Central Nervous System)
Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=1010752 .
Table of Contents:
Global Markets Direct Report Coverage
Insomnia - Overview
Insomnia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Insomnia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Insomnia - Companies Involved in Therapeutics Development
Insomnia - Drug Profiles
Insomnia - Dormant Projects
Insomnia - Discontinued Products
Insomnia - Product Development Milestones

List of Tables.
Number of Products under Development for Insomnia, H1 2017
Number of Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017
Products under Development by Universities/Institutes, H1 2017
Number of Products by Stage and Target, H1 2017
Insomnia - Pipeline by Actelion Ltd, H1 2017
Insomnia - Pipeline by Alexza Pharmaceuticals Inc, H1 2017
Insomnia - Pipeline by Athenex Inc, H1 2017
Insomnia - Pipeline by Johnson & Johnson, H1 2017
Insomnia - Pipeline by Leading BioSciences Inc, H1 2017
Insomnia - Pipeline by Merck & Co Inc, H1 2017
Insomnia - Pipeline by Shionogi & Co Ltd, H1 2017
Insomnia - Discontinued Products, H1 2017

About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on [email protected] with Yellow Fever Market in subject line and your contact details.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By ReportsnReports.com
Country India
Categories Health
Tags insomnia therapeutics , insomnia , insomnia market , insomnia pipeline , insomnia pipeline market
Last Updated May 26, 2017